| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 04/21/1993 | EP0537654A2 Anti-alpha6-integrin-antibodies |
| 04/21/1993 | EP0537575A1 Hydrobromide of DC-89 derivative having antitumor activity |
| 04/21/1993 | EP0537555A1 Crystalline etoposide 4'-phosphate diethanolate |
| 04/21/1993 | EP0537489A1 Monoclonal antibodies against tumor-associated antigens, method for their preparation and their use |
| 04/21/1993 | EP0537326A1 Rna delivery vector |
| 04/21/1993 | EP0537276A1 Cancer-associated scm-recognition factor, preparation and method of use |
| 04/21/1993 | EP0479871B1 Novel vitamin d analogues |
| 04/20/1993 | US5204107 Bound to deacetylated chitin; side effect reduction; sustained release over several months |
| 04/20/1993 | CA1316534C Tetrahydronaphthaline and indane derivatives |
| 04/20/1993 | CA1316533C Ornithine derivatives |
| 04/19/1993 | CA2080748A1 Heterobiaryl derivatives, pharmaceutical compositions containing these compounds and processes for preparing them |
| 04/19/1993 | CA2078817A1 Anti-.alpha.6-integrin-antibodies |
| 04/15/1993 | WO1993007286A1 Recombinant immunotoxins |
| 04/15/1993 | WO1993007283A1 Composition for inserting nucleic acid complexes into higher eucaryotic cells |
| 04/15/1993 | WO1993007273A1 Helicobacter pylori genes necessary for the regulation and maturation of urease, and use thereof |
| 04/15/1993 | WO1993007148A1 Novel potent inducers of terminal differentiation and methods of use thereof |
| 04/15/1993 | WO1993006867A1 The regulation of systemic immune responses utilizing cytokines and antigens |
| 04/15/1993 | WO1993006866A2 Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the cd2/lfa-3 interaction |
| 04/15/1993 | WO1993006824A1 Preparations containing transition-metal compounds for anti-tumour therapy and/or stimulating the haematopoietic system |
| 04/15/1993 | DE4134158A1 Verwendung von wasser- oder lipidloeslichen uebergangsmetallverbindungen pharmazeutische zubereitungen und verfahren zur herstellung pharmazeutischer zubereitungen fuer die antitumortherapie und/oder stimulierung des haematopoetischen systems Use of water or lipidloeslichen by transition metal compounds pharmaceutical preparations and process for manufacture of pharmaceutical preparations for the antitumor therapy and / or stimulation of the hematopoietic system |
| 04/14/1993 | EP0537008A1 Use of biphosphonates for the manufacture of a medicament for blocking neoplastic transformation of cells induced by ras oncogenes |
| 04/14/1993 | EP0537007A1 Use of formesyl-protein transferase inhibitors for the manufacture of a medicament for blocking neoplastic transformation of cells induced by ras oncogenes |
| 04/14/1993 | EP0536936A1 Pyrimidine nucleoside derivatives having anti-tumor activity, their preparation and use |
| 04/14/1993 | EP0536853A2 Process for the preparation of N1,N4-diethylspermine |
| 04/14/1993 | EP0536563A1 Nuclear inhibitor I-92 and its use for the production of a medicament |
| 04/14/1993 | EP0536322A1 HUMAN MACROPHAGE INFLAMMATORY PROTEIN 2$g(a) |
| 04/14/1993 | EP0536299A1 Surface complexed lymphotoxin |
| 04/14/1993 | EP0536275A1 Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof |
| 04/14/1993 | EP0536208A1 1,2-dihydro-3h-dibenzisoquinoline-1,3-dione anticancer agents |
| 04/14/1993 | CN1070946A Composition for introducing nucleic acid complexes into higher eucaryotic cells |
| 04/13/1993 | US5202456 Anticarcinogenic agents; methylating transferase inhibitors; farnesyl or geranyl sulfur-, oxygen or selenium-containing derivatives |
| 04/13/1993 | US5202352 Antitumor agents |
| 04/13/1993 | US5202317 Synthetic drug molecules that mimic metalloenzymes |
| 04/13/1993 | US5202314 10-thioethyl-steroids |
| 04/13/1993 | US5202244 Process for producing aphidicolin using the microrganism verticillium sp |
| 04/13/1993 | CA1316177C 1,2-bis(aminomethyl) cyclobutane platinum complexes |
| 04/12/1993 | CA2080172A1 Method for blocking neoplastic transformation of cells induced by ras oncogenes |
| 04/12/1993 | CA2080158A1 Method for blocking neoplastic transformation of cells induced by ras oncogenes employing bisphosphonates or analogs thereof |
| 04/10/1993 | CA2080054A1 17beta-substituted aza-androstane derivatives |
| 04/10/1993 | CA2079428A1 Pharmaceutical compounds |
| 04/08/1993 | CA2079733A1 Hydrobromide of dc-89 derivative |
| 04/07/1993 | EP0535731A2 Inhibitors of farnesyl protein transferase |
| 04/07/1993 | EP0535730A2 Inhibitors of farnesyl protein transferase |
| 04/07/1993 | EP0535337A2 Cell growth inhibiting activities of heparin binding neurite-outgrowth promoting factor |
| 04/07/1993 | EP0535336A2 MK protein as cell growth inhibitor |
| 04/07/1993 | EP0535231A1 Pyrimidine nucleoside derivative |
| 04/07/1993 | EP0535034A1 Pharmaceutically active benzoquinazoline compounds |
| 04/06/1993 | US5200553 Biologically active carboxylic acid esters |
| 04/06/1993 | US5200550 Administering for dermatologic, rheumatismal, respiratory or ophthalomologic disorders |
| 04/06/1993 | US5200536 Fluorine-containing vitamin D3 analogues |
| 04/06/1993 | US5200515 5'-trifluoromethyl-2'-deoxy-uridine phospholipid compounds |
| 04/06/1993 | US5200428 Enzyme inhibitors |
| 04/06/1993 | US5200397 Administering an oligopeptides anticoagulants or wound healing agents |
| 04/06/1993 | CA1315775C 4-demethoxy-4-amino-anthracyclines |
| 04/06/1993 | CA1315685C Pharmaceutical compositions based on benzoic benzopyranyl and benzothiopyranyl compounds |
| 04/06/1993 | CA1315682C Injection containing 3-benzoyloxy-1,3,5(10)-estratriene -17-¬4- p-(bis(2-chloroethyl)amino)phenyl -butanoyloxy| acetate as an active |
| 04/01/1993 | WO1993006231A1 Anti-human milk fat globule humanised antibodies |
| 04/01/1993 | WO1993006213A1 Production of chimeric antibodies - a combinatorial approach |
| 04/01/1993 | WO1993006124A1 11β-SUBSTITUTED 14,17-ETHANOESTRATRIENES, PROCESS FOR PREPARING THESE COMPOUNDS AND THEIR USE FOR PREPARING MEDICAMENTS |
| 04/01/1993 | WO1993006120A1 Phosphoramidate analogs of 5-fluoro-2'-deoxyuridine |
| 04/01/1993 | WO1993006093A1 10-desacetoxytaxol derivatives |
| 04/01/1993 | WO1993006086A1 Retinoids and their use in treating skin diseases and leukemia |
| 04/01/1993 | WO1993005781A1 Novel alpha-mannosidase inhibitors |
| 04/01/1993 | WO1992022583A3 Tri- and tetra-valent monospecific antigen-binding proteins |
| 04/01/1993 | CA2119780A1 11.beta.-substituted 14,17-ethanoestratrienes, process for preparing these compounds and their use for preparing medicaments |
| 04/01/1993 | CA2119571A1 Retinoids and their use in treating skin diseases and leukemia |
| 03/31/1993 | EP0534742A1 Anti-human milk fat globule humanised antibodies |
| 03/31/1993 | EP0534709A1 Substituted taxanes as antitumour agents |
| 03/31/1993 | EP0534708A1 Furyl and thienyl substituted taxanes as antitumour agents |
| 03/31/1993 | EP0534707A1 Alkoxy substituted taxanes as antitumour agents |
| 03/31/1993 | EP0534137A2 Kedarcidin antitumor chromophore |
| 03/31/1993 | EP0534097A2 Use of NADH or NADPH against cancer or AIDS |
| 03/31/1993 | EP0533744A1 Heterocyclic anthracyclione and anthracycline analogs |
| 03/31/1993 | EP0533692A1 Mitomycin derivatives having reduced bone marrow toxicity, processes for their preparation, and the uses thereof |
| 03/31/1993 | EP0407461B1 Novel cyclopentano-vitamin d analogs |
| 03/31/1993 | CN1020194C Method for preparation of difluorated nucleoside derivant |
| 03/31/1993 | CA2079291A1 Activities of heparin binding neurite-outgrowth promoting factor |
| 03/31/1993 | CA2079290A1 Activities of mk protein |
| 03/31/1993 | CA2079254A1 Inhibitors of farnesyl protein transferase |
| 03/31/1993 | CA2079253A1 Inhibitors of farnesyl protein transferase |
| 03/30/1993 | US5198560 Cytotoxic bicyclo[7.3.1]tridec-4-ene-2,6-diyne compounds and process for the preparation thereof |
| 03/30/1993 | US5198460 Pyropheophorbides and their use in photodynamic therapy |
| 03/30/1993 | CA1315278C N-(vinblastinoyl-23) derivatives of amino-methylphosphonic acid, processes for their preparation and pharmaceutical compositions containing them |
| 03/30/1993 | CA1315230C Antibiotics, process for their preparation and pharmaceutical compositions containing them |
| 03/30/1993 | CA1315219C Monoclonal antibodies against human carcinoembryonic antigen, processes for their production and their use |
| 03/27/1993 | CA2075453A1 Kedarcidin antitumor chromophore |
| 03/24/1993 | EP0533504A1 Dihydropyridine derivatives useful in antitumor therapy |
| 03/24/1993 | EP0533199A2 Application to a chimeric antibody directed against ganglioside GD3 |
| 03/24/1993 | EP0532716A1 New synthethic peptides with imunomodulating activity and preparation thereof |
| 03/24/1993 | EP0532636A1 Bis-naphthalimides as anticancer agents |
| 03/24/1993 | EP0532531A1 Phenol and pyridinol derivatives as pharmaceuticals |
| 03/24/1993 | EP0532525A1 New protein-polycation conjugates. |
| 03/24/1993 | EP0376959B1 Platinum pharmaceuticals |
| 03/24/1993 | EP0345315B1 Ps2 protein derivative |
| 03/24/1993 | CN1070227A DNA sequences encoding gelonin polypeptide |
| 03/23/1993 | US5196522 Anthracycline analogues bearing latent alkylating substituents |
| 03/23/1993 | US5196447 Neristatin 1 |
| 03/23/1993 | US5196435 Melatonin derivatives and combinations with antiestrogen compounds for treating mammalian breast carcinoma |
| 03/23/1993 | US5196424 Antitumor |
| 03/23/1993 | US5196412 Treatment of excess calcium |